These clinical data on PPAR-γ-induced signaling implicated in the expression of crucial angiogenicfactors in human neoplasia may unfold the development of new therapeuticapproaches in those types of cancer in which excessive angiogenesis representsa negative prognostic factor. The gene discussed is PPARG; the disease is cancer.